Amicus Therapeutics Inc
NASDAQ:FOLD
Balance Sheet
Balance Sheet Decomposition
Amicus Therapeutics Inc
Current Assets | 498.5m |
Cash & Short-Term Investments | 249.8m |
Receivables | 98.1m |
Other Current Assets | 150.6m |
Non-Current Assets | 288.1m |
PP&E | 53.6m |
Intangibles | 215.8m |
Other Non-Current Assets | 18.7m |
Balance Sheet
Amicus Therapeutics Inc
Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | |||||||||||
Cash & Cash Equivalents |
24
|
70
|
187
|
49
|
80
|
143
|
163
|
245
|
149
|
247
|
|
Cash Equivalents |
24
|
70
|
187
|
49
|
80
|
143
|
163
|
245
|
149
|
247
|
|
Short-Term Investments |
128
|
145
|
143
|
310
|
424
|
310
|
320
|
237
|
145
|
39
|
|
Total Receivables |
0
|
0
|
1
|
10
|
22
|
33
|
47
|
53
|
66
|
88
|
|
Accounts Receivables |
0
|
0
|
1
|
10
|
22
|
33
|
47
|
53
|
66
|
88
|
|
Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Inventory |
0
|
0
|
3
|
5
|
8
|
14
|
20
|
27
|
24
|
60
|
|
Other Current Assets |
3
|
3
|
5
|
19
|
17
|
20
|
30
|
35
|
40
|
50
|
|
Total Current Assets |
155
|
217
|
340
|
392
|
551
|
520
|
580
|
597
|
424
|
483
|
|
PP&E Net |
3
|
6
|
10
|
9
|
11
|
81
|
67
|
63
|
60
|
58
|
|
PP&E Gross |
3
|
6
|
10
|
9
|
11
|
81
|
67
|
63
|
60
|
58
|
|
Accumulated Depreciation |
12
|
13
|
13
|
13
|
16
|
23
|
22
|
20
|
22
|
25
|
|
Intangible Assets |
23
|
487
|
487
|
23
|
23
|
23
|
23
|
23
|
23
|
20
|
|
Goodwill |
12
|
198
|
198
|
198
|
198
|
198
|
198
|
198
|
198
|
198
|
|
Long-Term Investments |
18
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Long-Term Assets |
1
|
1
|
3
|
5
|
7
|
28
|
19
|
24
|
19
|
19
|
|
Other Assets |
12
|
198
|
198
|
198
|
198
|
198
|
198
|
198
|
198
|
198
|
|
Total Assets |
210
N/A
|
908
+333%
|
1 037
+14%
|
627
-40%
|
790
+26%
|
850
+8%
|
887
+4%
|
905
+2%
|
724
-20%
|
778
+7%
|
|
Liabilities | |||||||||||
Accounts Payable |
6
|
17
|
13
|
16
|
44
|
51
|
17
|
22
|
15
|
15
|
|
Accrued Liabilities |
11
|
16
|
28
|
37
|
36
|
69
|
88
|
95
|
89
|
130
|
|
Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Current Portion of Long-Term Debt |
4
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Current Liabilities |
0
|
41
|
70
|
16
|
6
|
9
|
24
|
29
|
35
|
23
|
|
Total Current Liabilities |
20
|
74
|
111
|
70
|
86
|
129
|
130
|
146
|
139
|
168
|
|
Long-Term Debt |
11
|
0
|
155
|
164
|
322
|
150
|
389
|
389
|
392
|
388
|
|
Deferred Income Tax |
9
|
176
|
174
|
7
|
7
|
5
|
5
|
5
|
5
|
0
|
|
Other Liabilities |
48
|
311
|
238
|
34
|
33
|
90
|
76
|
58
|
65
|
62
|
|
Total Liabilities |
88
N/A
|
561
+538%
|
677
+21%
|
274
-59%
|
447
+63%
|
374
-16%
|
600
+61%
|
598
0%
|
601
+1%
|
618
+3%
|
|
Equity | |||||||||||
Common Stock |
1
|
1
|
2
|
2
|
2
|
3
|
3
|
3
|
3
|
3
|
|
Retained Earnings |
447
|
571
|
764
|
1 048
|
1 399
|
1 756
|
2 033
|
2 296
|
2 532
|
2 684
|
|
Additional Paid In Capital |
569
|
918
|
1 120
|
1 401
|
1 740
|
2 227
|
2 309
|
2 595
|
2 665
|
2 836
|
|
Unrealized Security Profit/Loss |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Other Equity |
0
|
0
|
2
|
2
|
1
|
3
|
8
|
5
|
12
|
5
|
|
Total Equity |
122
N/A
|
348
+185%
|
360
+4%
|
353
-2%
|
343
-3%
|
476
+39%
|
286
-40%
|
307
+7%
|
123
-60%
|
160
+30%
|
|
Total Liabilities & Equity |
210
N/A
|
908
+333%
|
1 037
+14%
|
627
-40%
|
790
+26%
|
850
+8%
|
887
+4%
|
905
+2%
|
724
-20%
|
778
+7%
|
|
Shares Outstanding | |||||||||||
Common Shares Outstanding |
96
|
125
|
143
|
167
|
189
|
255
|
262
|
279
|
281
|
294
|